An exploratory study on the checkout rate of circulating tumor cells and the prediction of efficacy of neoadjuvant therapy and prognosis in patients with HER-2-positive early breast cancer

BackgroundNeoadjuvant therapy is a standard treatment for patients with large, nonmetastatic breast cancer and may allow breast-conserving surgery after tumor downsizing while decreasing the risk of subsequent relapse. Dynamic changes of circulation tumor cells (CTCs) have a role in predicting treat...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Jinmei Zhou, Jiangling Wu, Xiaopeng Hao, Ping Li, Huiqiang Zhang, Xuexue Wu, Jiaxin Chen, Jiawei Liu, Jinyi Xiao, Shaohua Zhang, Zefei Jiang, Yanlian Yang, Zhiyuan Hu, Tao Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Subjects:	circulating tumor cells (CTCs) neoadjuvant therapy liquid biopsy prognostic breast cancer HER-2-positive early breast cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.966624/full